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Background: Wales faces serious public health challenges, with relatively low life expectancies and wide
inequalities in life expectancy with associated pressures on the National Health Service (NHS) at a time of financial
recession. This has led to growing recognition of the need to better understand the range of health improvement
and prevention programmes across Welsh Government, NHS, local government and voluntary sector agencies.
Methods: The Minister for Health and Social Care commissioned Public Health Wales, the single national public
health organisation, to establish a Health Improvement Advisory Group, to oversee a Programme Budgeting and
Marginal Analysis (PBMA) expert panel. The panel drew on evidence from a range of sources to explore potential
alternative modes of health improvement initiative delivery across Wales. Electronic voting was used to agree an
appropriate time horizon for health improvement programme outcomes, main objective of the health
improvement review and criteria for evaluating candidate services for disinvestment and investment. The panel also
used electronic voting to state whether they wished to disinvest or invest in a candidate service.
Results: The review identified a budget of £15.1 million, spanning 10 Welsh Government priority areas, and 6 life
course stages. Due to lack of evidence the panel recommended total disinvestment in 7 out of 25 initiatives
releasing £1.5 million of resources, and partial disinvestment in a further 3 interventions releasing £7.3 million of
resources. The panel did not recommend increasing investment in any of the 25 initiatives under review. Marginal
analyses prioritised child health, mental health and wellbeing and tobacco control as key areas for investment.
Conclusions: Wales is championing a concept of “prudent healthcare”. The PBMA exercise undertaken here was a
transparent evidence-based tool to reach decisions about potential for disinvestment and reinvestment in health
improvement strategies. It also demonstrates the potential wider application at a national level across government
public health functions, to ensure resources are most cost-effectively deployed, with due consideration for equity.
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Table 1 The eight stages of PBMA by Brambleby and
Fordham
Stage Description
1 Choose a set of meaningful programmes/initiatives.
2 Identify current activity and expenditure in those
programmes/initiatives.
3 Think of improvements.
4 Weigh up incremental costs and incremental
benefits and prioritise a list.
5 Consult widely.
6 Decide on changes.
7 Effect the changes.
8 Evaluate progress.
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Public health challenges in Wales
Despite an increase in healthy life expectancy in Wales
in recent years, local authorities continue to experience
among the worst life expectancies in the UK, and the
gap between the most and least deprived remains wide.
Smoking causes about 1 in 5 deaths in Wales [1]. Preva-
lence is currently 23% and is highest in young Males
aged 25–34 at 38% [1]. About 45% of the population
drink above guideline amounts of alcohol, over 1000
people a year die from alcohol in Wales, and there are
over 55,000 hospital admissions due to alcohol in Wales
per year [2]. Only about a third of adults eat 5 fruit and
vegetables a day, under a third meet physical activity
guidelines with about 30% of the adult population taking
no exercise in a typical week [2]. As a consequence of
unhealthy eating and low physical activity, 57% of the
Welsh adult population is overweight or obese [2]. There
is a growing need from policy makers for interventions
that address the above challenges, but are also considered
a good use of public resources. The cost-effectiveness
evidence base for public health interventions is beginning
to grow.
Growing evidence of the cost-effectiveness of public
health interventions
Owen et al., 2011 have synthesised the evidence of the
cost-effectiveness of public health interventions underpin-
ning National Institute for Health and Care Excellence
(NICE) Public Health Guidance from 2006–2010 [3]. They
analysed 200 base-case cost-effectiveness estimates. Find-
ings showed the majority of public health interventions
assessed were highly cost-effective, 85% of which had an
incremental cost-effectiveness ratio less than £20,000 per
Quality Adjusted Life Year (QALY) and 89% at the higher
threshold of £30,000 per QALY [3]. The authors conclude
that the next step would be to develop a framework that
allows the combination of economic analysis and other
criteria to support local decision makers to make better
investments. Although there is a need for quality evidence
from Randomised Controlled Trials (RCTs) that pay par-
ticular attention to the challenges of conducting economic
evaluations of complex (as defined by the Medical Research
Council (MRC)) [4] public health interventions as recom-
mended by Kelly et al. (2005), McDaid & Needle, (2008)
and Weatherly et al. (2009), [5-7], there is also a need for
expert opinion and common sense. Programme Budgeting
Marginal Analysis can be employed as a means of using
expert opinion as a part of evidence based decision
making.
Programme Budgeting and Marginal Analysis (PBMA)
Programme Budgeting and Marginal Analysis (PBMA) is
a process that helps decision-makers maximise the impactof healthcare resources on the health needs of a local
population or meet other specified goals such as equity
considerations. Programme budgeting is an appraisal of
past resource allocation in specified programmes, with a
view to tracking future resource allocation in those same
programmes. Marginal analysis is the appraisal of the
added benefits and added costs of a proposed investment
or the lost benefits and lower costs of a proposed dis-
investment [8,9]. Some programmes can absorb a degree
of contraction, whilst still continuing e.g. through better
targeting. It is important to be aware of the links across
programmes and, therefore, how changes in expenditure
on one programme may impact on others. The PBMA
process requires information on expenditure by programme
for example, by an annual budget and/or numbers of
full time equivalent posts (WTE). The stages of a PBMA
exercise are shown in Table 1 below.
A recent review considered factors that may explain the
success or otherwise of PBMA exercises [10]. Tsourapas &
Frew (2011) found 28 applications of PBMA spread across
the UK, Australia, New Zealand and Canada [10]. Find-
ings showed PBMA was successful in 52% of cases where
success was defined in terms of the participants gaining a
better understanding of the area under interest [10].
PBMA was successful in 65% of cases where success was
defined as ‘implementation of all or some of the PBMA
panel’s recommendations’ [10]. Forty-eight percent of the
studies were successful where success was defined in
terms of disinvesting or resource reallocation; and in 22%
where success was defined in terms of adopting the frame-
work for future use [10]. The authors concluded that the
definition of success influenced the rate of successful
PBMA applications. They argue for a broadly accepted
definition of success to allow greater comparability within
the field [10].
There has also been more recent use of PBMA as a
framework for disinvestment [11]. When conducting a
rapid review of applied PBMA framework, we found
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[12], Surgical Department [13], gynaecology services [14]
and GP led community hospital care for stroke patients
[15]. This paper describes a national PBMA exercise of the
annual health improvement budget of the Welsh Minister
for Health and Social Care. We believe this to be the first
published description of a PBMA exercise at a national
level [16].
Methods
We describe below the process of conducting the PBMA
exercise, with particular reference to the perspective,
development of the panel, gathering of evidence and the
marginal analysis task.
Perspective of the health improvement review
This PBMA exercise was completed on behalf Public
Health Wales and considered public health interventions
at a national level, taking into account NHS services and
those provided by public and private partners. This
PBMA exercise assessed the health improvement budget
of the Minister for Health and Social Care. At the begin-
ning of the process health improvement was defined under
the Ottawa Charter (1986) [17]. This definition of health
improvement highlights the importance of reorienting
health services, creating supportive environments, im-
proving personal skills, community action, and the role of
healthy public policy. Once the perspective was established,
a panel was established to review the evidence gathered
and reach the disinvestment/investment decisions.
Development of a PBMA panel
An expert panel list of 30 potential members was estab-
lished with representatives from: Public Health Wales,
Welsh Government, NHS Health Boards, third sector,
local government and primary care. Each member of the
suggested panel was sent an invitation to participate in
the PBMA exercise by e-mail. The e-mail described the
purpose of the exercise, the invited member’s role in the
panel, the commitment required and the dates and times
of the proposed meetings. The invited members were
able to decline to participate, and panel members who
agreed to participate were able to withdraw their mem-
bership at any time. As this was a government initiated
evidence based, decision making exercise ethical approval
was not required.
Once the budget was defined, the researchers were in-
formed that the budget contained 25 initiatives, accounting
for the total £15.1 million of the Minister’s spend in health
improvement across Wales. The panel drew upon evidence
collated for each initiative from the review sub-groups,
stake holder consultation and an NHS/ primary care
sub-group to explore potential alternative modes of health
improvement delivery across Wales. The PBMA panelmet three times and the sessions were facilitated by a
session leader. The sessions started with an explanation of
the exercise and the review of evidence undertaken. A
discussion of the criteria to appraise the evidence was also
conducted with a list of six final criteria agreed by the
panel. These criteria were as follows: considered a priority
health issue for Welsh Government, opinions of experts,
stakeholder views, presence and robustness of evidence of
effectiveness, presence and robustness of evidence of cost-
effectiveness and impact or potential impact on reducing
inequalities in health. The options above were used as part
of the electronic voting exercise. The panel were then
asked to vote electronically on the preferred objective of
the Health Improvement Review, the top four criteria for
the health improvement review from 12 PBMA panel
members and to agree the most relevant time horizon for
this PBMA exercise. The vote was conducted and then
the results were displayed electronically using graphics
and discussed, with an opportunity to revote if required.
The panel were given the evidence underpinning each of
the initiatives to read between the second and third
session. At the third session, the panel were asked to vote
for candidates for investment and disinvestment. The vote
was conducted; the results were displayed and discussed,
with an opportunity to revote if required.
Boundaries of the programme budget
This programme was a historically determined programme
budget of Ministerial resources currently devoted specific-
ally to health improvement at an All Wales level. There are
other resources known to be used for health improvement
purposes, sometimes matched with Local Government or
voluntary sector spending. However, these were considered
outside the remit of this analysis.
The review established five operational sub-groups to
support the review, as outlined below. Information from
each of these groups was summarised and then combined
and collated into summary booklets for each initiative.
During this summary process the review teams decided
that a scoring system was required to help guide the panel.
A traffic light system was agreed as the most appropriate
and visually effective structure. Each of the evidence re-
view sub-teams applied a traffic light rating system to their
particular stream of evidence and then an overall traffic
light grading was assigned to each initiative based upon all
the available evidence gathered by the sub-groups. The
overall traffic light grading was as follows: Red – based on
published evidence and consultation, this intervention is
unlikely to bring a population health benefit and alterna-
tives should be explored to achieve these health goals.
Amber - greater evidence needs to be found for the im-
pact of this initiative at a population level and/or there
are elements of the programme that need substantial
revision or there is insufficient evidence available to make
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reasonable evidence base; however, we need to ensure that
reach is maximised and it is cost effective. See Additional
file 1 for a description of the evidence booklet method-
ology. These booklets were distributed to the PBMA panel
members for their consideration before the sessions.
Protocol for review of effectiveness evidence
A pragmatic search strategy was designed using specified
health databases (NHS Evidence, Cochrane Collaboration,
Cambell Collaboration, Health Evidence Canada) and the
search-engines (PubMEd and Google Scholar). For initia-
tives where recent high quality secondary analyses of the
primary literature were found, searches were narrower
and terminated at an earlier stage. Searches for questions
that yielded little high quality data initially were broadened
by date or by search terms in an attempt to capture re-
lated work. Retrieved articles were screened for inclusion
by two independent reviewers (disagreements resolved by
discussion), on the basis of direct relevance to the initia-
tive or component interventions and type of article, thus
single studies were not included if higher level evidence
was available. Evaluations of interventions in practice were
also sought and interventions were assigned an overall
evidence rating taking into account potential and actual
evidence of effectiveness.
Protocol for review of cost-effectiveness evidence
Relevant articles identified from an evidence search
(2002–2012) of NICE, Pub-Med and the Centre for
Reviews and Dissemination (CRD) Database using key
terms from each of the 25 initiatives were sourced and
then appraised. Evidence was defined as; directly relevant
i.e. an economic evaluation of a specific intervention
delivered through the programme/initiative stated in
the list of included programmes; or indirectly relevant
(where directly relevant evidence is unavailable) i.e.
evaluation of related intervention similar to the one
delivered through the programme/initiative or as part
of the intended aims of the programme/initiative stated in
the list of included programmes by either method of deliv-
ery (school-based smoking cessation) or target population
(pregnant women). The Drummond et al. (2005) checklist
for a sound economic evaluation was used to appraise
evidence found in the electronic searches [18]. A subject-
ive judgement of the overall balance of economic evidence
was made by the economic evidence sub-group and a traf-
fic light system of grading was used.
Stakeholder consultation process
The review involved wide consultation to gain opinions
of stakeholders such as practitioners delivering the initia-
tives and the public who may have come into contact with
particular initiatives. These were used in the evidencebooklets to give the panel an indication of stakeholder
views. This was undertaken as part of a wider “change
management” strategy to ensure the public had oppor-
tunity to discuss any possible changes to services and
relay their concerns so policy makers could understand
the potential impacts. The consultation process involved a
range of engagement events including; visits to local pub-
lic health teams across the 7 health boards, these teams
were often involved with the delivery of health improve-
ment programmes, visits with Public Health Wales staff.
Beaufort Research were commissioned to undertake a pub-
lic survey and to conduct six focus groups and six in-depth
family interviews. Eight consultation events were held
across Wales addressing the initiatives with regards to
different stages of the life course. An open online feedback
form was hosted on the bilingual review web pages on the
Public Health Wales website, to further engage the public
and staff. Responses were assigned a traffic light system
based upon the overall majority of positive, negative and
mixed feedback from each of the groups.
Equity review
The extent to which each of the initiatives addressed
equity concerns was also supplied in the evidence book-
lets. A traffic light categorisation system was developed to
grade the degree of equality/equity focus of each initiative
under review. Some of these initiatives have a degree of
complexity which required explanation in addition to the
traffic light grading. These include some where there has
been a change of focus since inception and others where
programme employees act as intermediaries and local
areas are largely autonomous in the way initiatives are de-
livered. It should be noted that the categories apply to the
intention of the programme rather than the supporting
evidence, effectiveness or cost-effectiveness, which have
been reviewed separately.
NHS/primary care consideration
The evidence booklets also detailed options for alternative
modes of delivery through existing mainstream services.
The mechanism of delivery was summarised with consid-
eration given to alternatives where appropriate.
Those directly involved in the intervention delivery or
commissioning of services were invited to correct matters
of accuracy and supply additional evidence for consider-
ation. This was reviewed and a final assessment agreed by
the panel.
We went on to undertake a pragmatic high-level
marginal analysis task as part of the PBMA process.
Marginal analysis
Three months following the PBMA sessions all members
of the PBMA panel and HIAG received a high level prag-
matic marginal analysis electronic task and supporting
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ents with a refresher of the PBMA sessions, including
grading of evidence and the outcomes of electronic voting
for criteria and investment/disinvestment decisions. As
the panel did not wish to continue investing in any of the
current programmes, based on available evidence, a high
level task was developed in which the recipients were
asked to consider what Public Health Wales should do
with a hypothetical £5 million. This sum of money was
chosen based upon the median amount of monies released
from the recommended disinvestment and partial dis-
investment decisions made by the panel. The panel and
HIAG members were asked to rank, in order of import-
ance, their top 3 priority areas (out of a choice of 11) and
their top 3 life course stages (out of a choice of 6), in
which new approaches to health improvement should be
developed with this hypothetical £5 million. They were
also asked to state how much of the £5 million they would
allocate to each of their top 3 choices and to give a brief
rationale for their choices.
Results
The programme budget
We identified 25 specific health improvement initiatives
within the programme budget, see Table 2 below. See
Additional file 2 for a brief description of each of the initia-
tives. There were a number of initiatives where no or little
evidence was available. Economic evidence was sparse; with
11 of the 25 initiatives having no available evidence of cost-
effectiveness, cost-utility or cost-benefit. A total of 12 panel
members attended each of the 3 PBMA sessions.
Nineteen of the 25 initiatives included in the PBMA
exercise received an overall evidence traffic light grading
of red or amber, stating alternatives should be explored
to achieve the health improvement goals outlined by the
initiative or required further evidence. Fifteen of the 25
initiatives had no economic evidence.
Spending by life course stage
Figure 1 illustrates the prevailing spending per life course
stage of the £15 million of the identified programme
budget.
Establishing criteria for evaluating the programme and
candidate interventions for investment and disinvestment
The 12 PBMA panel members were asked, using electronic
voting to identify criteria with which to judge the relative
merit of candidate interventions for investment and
disinvestment see Tables 3, 4 and 5.
Generating candidate initiatives for investment and
disinvestment
Figure 2 illustrates that the PBMA panel was able to reach
a majority vote to recommend disinvestment in 7 out of25 initiatives releasing £1.5 million per annum (The
Cooking Bus, Smoke Bugs, Skin Cancer Awareness, Health
Challenge Wales Website, Mind, Exercise, Nutrition…
Do it! (MEND), Mental Health First Aid and Smokers
Helpline). Although the overall health improvement
goals were rational, it was stressed that this was on the basis
of a lack of evidence of effectiveness, cost-effectiveness or
support from local public health teams, or any evidence of
impact on inequality.
These results did not mean that the target stages of
the life course e.g. primary school children, or the goal of
limiting health harming behaviours were less important
than other goals, rather that such goals should be ad-
dressed in other, evidence based ways e.g., environmental
change. The PBMA panel also recommended partial dis-
investment in a further three interventions releasing £7.3
million of resources, including some big spend areas such
as Designed to Smile and National Exercise Referral
Scheme. Because of a lack of published evidence at the
time of effectiveness, cost-effectiveness and impact on
inequalities, the panel did not vote in any majority
fashion to invest further in any of the 25 interventions
under review. Following this, a high level marginal analysis
task was developed to assess which priority areas and life
course stages the PBMA group would like to invest in.
Priority areas were defined by the Welsh Government’s
‘Our Healthy Future’ report [19].
Results of the marginal analysis task
We received 9 completed Marginal Analysis tasks from
the panel and HIAG members out of a possible 30 re-
sponses. Though disappointing, the 9 respondents were
representative of the wider panel with regards to their role
and expertise spanning Public Health Wales, Welsh
Government, Health Boards, local government and primary
care.
As shown in Table 6, respondents allocated the largest
proportion of the hypothetical £5 million to their first
choice priority area and the smallest proportion to their
third choice priority area. Only one respondent gave
an equal division of the £5 million to each of the 3
rankings. Obesity was given the largest proportion of the
£5 million, followed by: Mental Health and Wellbeing,
Tobacco Control, Nutrition, Substance misuse, physical
activity, Injuries and finally Oral Health. The rationale
for respondents’ choices were mainly based upon the
large adverse costs and impacts on the population of
poor population health in these priority areas, with the
potential for large benefit if these areas were given funding
and priority. One respondent stated their decisions were
based upon key local priorities. Another respondent stated
their decisions were based on their view that two priority
areas were generally underfunded, though could have wide
ranging benefits.
Table 2 The 25 initiatives identified in the PBMA exercise
Initiative Approx. spend 2012/13 Assessment category
Cooking Bus £655 k Red – Based on published evidence
and consultation, this intervention is
unlikely to bring a population health
benefit and alternatives should be
explored to achieve these health goals.
MEND £480 k
Mental Health First Aid £143 k
Smokebugs £131 k
National Breastfeeding Programme – Breastfeeding
Peer Support Programme (BPSP)
£31 k
National Breastfeeding Programme – Breast-feeding
Welcome Scheme (BFWS)
£11 k
Health Challenge Wales website Cost £38 k
Smokers Helpline £30 k
Smoking Resources £30 k
Skin Cancer Awareness £15 k
Designed to Smile £3.75 M Amber - Greater evidence needs
to be found for the impact of this
initiative at a population level.
and/or There are elements of the
programme that need substantial
revision or There is insufficient
evidence available to make a
judgment
Welsh Network of Healthy Schools Schemes £2.3 M
Stop Smoking Wales – Pre Surgery £2.2 M (NB total spend on SSW
over 5 programmes as it was
not possible to break spend down
to individual programmes)
Stop Smoking Wales – Pregnancy
Stop Smoking Wales – Vulnerable Groups
Stop Smoking Wales – Brief Intervention Training
Fresh Start Wales £700 k
Alcohol Brief Interventions in Primary Care Training £100 k
HIV Prevention £56 k
National Exercise Referral Scheme £3.5 M Green - This is a sound programme
with a reasonable evidence base
however we need to ensure that
reach is maximised and it is cost
effective.
Stop Smoking Wales – Adults £2.2 M (NB spend over 5
programmes as it was not
possible to break spend down
to individual programmes)
ASSIST £300 k
National Breastfeeding Programme - Baby Friendly
initiative (BFI)
£110 k
No Smoking Day £27 k
Teenage Pregnancy Pilot £150 k White – a Pilot
Steroids and Image Enhancing Drugs £50 k White – insufficient information to
make an assessment.
Champions for Health £30 k White – It is not clear what theoretical
or evidence base has been used in
planning this intervention. Without
an evaluation (which specifies and
measures primary outcomes) wider
implementation cannot be
recommended.
The 25 initiatives identified in the PBMA exercise with an overall traffic light grading and summary statement from the five evidence sub-group categories (total
of £15 million expenditure).
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dents allocated the largest proportion of the hypothetical
£5 million to their first choice life course stage and the
smallest proportion to their third choice life course stage.
However, one respondent allocated the largest proportion
to their third ranking as they felt this life area was often
neglected and underfunded. The rationale for respondents’choices was mainly based upon the view that focusing on
early intervention could provide the greatest potential to
gain in the long-term. The early years life course stage re-
ceived the highest number of first rankings. Respondents
also stated that keeping older people healthy for as long as
possible could have huge potential public health gains and
savings to the NHS and social care sectors.
Figure 1 Spending by life course stage of the 25 health improvement initiatives. Spending on the 25 health improvement initiatives by
each life course stage.
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implemented in Wales
As part of the next steps of the PBMA exercise and rec-
ommendations, it was stated that the evidence gathering
exercise identified areas where Wales was not implement-
ing existing NICE public health recommendations. Unlike
NICE clinical guidelines, NICE public health guidance is
not commissioned by the Welsh Government. Nonethe-
less, the recommendations of NICE are evidence based
and would have similar value in Wales as in England.
There is limited information on the extent of implementa-
tion of NICE public health guidance in Wales. There is
potential for the introduction of systematic implementa-
tion and monitoring of NICE recommendations in Wales.
There are a number of existing programmes where greaterTable 3 Preferred objective of the health improvement
review electronic vote results
Objective Percentage vote n
A housekeeping exercise of current
patterns of spending
8% 1
A means of bringing a culture of
evidence based decision making
into routine policy
42% 5
An academic exercise to explore
the degree of success achieved
in applying PBMA
8% 1
A means of bringing evidence of
cost-effectiveness into resource
planning
42% 5impact could be achieved through more systematic target-
ing and implementation, more robust monitoring and
greater reach. There are a number of interventions with
evidence of effectiveness not currently being implemented
in Wales [see Additional file 3].
Discussion
This PBMA exercise has generated practical policy lessons
for Welsh Government, Public Health Wales and their
partner agencies. Though PBMA has been applied in a
range of clinical settings in the UK and internationally
e.g., maternity services, it has not to our knowledge
been used at a national level to review a whole programme
of public health spending. The results from this PBMA
exercise were used to inform the Public Health Wales
report ‘Transforming Health Improvement in Wales’
which makes recommendations for reinvestment andTable 4 The top four criteria for the health improvement
review electronic vote results
Criteria Percentage vote n
Stakeholder views 20% 2
Presence and robustness of evidence
of effectiveness
34% 4
Presence and robustness of evidence
of cost-effectiveness
27% 3
Impact or potential impact on reducing
inequalities in health
19% 2
Results of the electronic vote for the top four criteria for the health improvement
review from 12 PBMA panel members.
Table 5 The most relevant time horizon to assess outcomes
of the health improvement programmes under review
Time horizon Percentage vote n
1 year 8% 1
5 years 50% 6
10 years 17% 2
15 years 8% 1
20 years 17% 2
Other 0% 0
Results of the electronic vote for the most relevant time horizon that should
be used in this PBMA based review of health improvement programmes in
Wales – it was stated to the panel in the session that this time horizon related
to outcomes rather than the process of the review.
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for health improvement in Wales [20]. The budget pre-
sented for this PBMA exercise was historical within
the behest of the Minister for Health and Social Care
for Wales. It was split in terms of 70% allocated via
Public Health Wales and 30% directly allocated by
Welsh Government. What became clear through the
PBMA process was the importance of a programme
having a logical and comprehensive boundary. The
£15.1 million did not represent the total spending on
health improvement across Wales and it is likely thatFigure 2 Investment and disinvestment decisions made by the panel
disinvestment recommendations from votes made by the PBMA panel (n =
considered as pilots (Teenage Pregnancy Pilot, Steroids and Image Enhancmany examples might be found of matched funds,
through arrangements between Welsh Government, local
Government, the voluntary sector and other agencies. It
became difficult for the members of the PBMA group to
comprehend the task of reallocating the £15.1 million
without full knowledge of what resources, and what inter-
ventions, were being devoted to tackling health improve-
ment issues outside the programme budget under review.
The same argument could be made for previous published
PBMA exercises. For example, Twaddle and Walker
reviewed gynaecological services in Glasgow [14]. In
hindsight, they may have benefited from consideration
of a wider context of spending e.g. across primary care,
other hospitals and other related agencies.
QALYs in public health
Despite a growing view that QALYs may be an insufficient
outcome measure to fully capture the benefits of public
health interventions [5-7,21], 85% of 200 cost per QALY
estimates relating to NICE public Health Guidance
produced a cost-per QALY of under the NICE threshold
of £20,000 per QALY [3]. We found that in reviewing evi-
dence of cost-effectiveness it was necessary to try to find
common units of benefit with which to compare across a
whole range of health improvement interventions. QALYs,for each of the 25 initiatives. Candidates for investment and
12) for the 25 initiatives under review. Please note the initiatives
ing Drugs and Champions for Health) were not included in the voting.
Table 6 Results of the marginal analysis ranking exercise for the 11 priority areas from the 9 respondents
Priority area Total number of times the
area was assigned 1st ranking
Total number of times the area
was assigned 2nd ranking
Total number of times the
area was assigned 3rd ranking
Tobacco control 1 2 2
Physical activity 1 0 0
Nutrition 0 0 2
Oral health 0 0 1
Obesity 3 3 1
Substance misuse 0 1 1
Sexual health 0 0 0
Injuries 1 0 0
Mental health and wellbeing 3 2 1
Public health education 0 0 0
Work and health 0 1 1
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gained were most useful. What proved to be more difficult
was the ability to use information on cost-effectiveness
studies which used natural units of effect directly relevant
to the public health intervention concerned (e.g., point
change on a child behaviour index, minutes of exercise
per week, number of smokers quitting). This PBMA exer-
cise reinforced the argument for common units of benefit
for the purpose of comparing across a whole programme
of interventions, even in a public health setting.
We found few return on investment studies, or cost-
benefit studies of public health improvement interventions.
Placing monetary values on health outcomes, whether clin-
ical or public health remains difficult, though cost-benefit
analysis and cost-consequence analysis are recommended
by NICE [22].
Public health – invest to save
There is a growing interest amongst health care commis-
sioners and local government for the concept of “invest to
save” to be applied to public health interventions. This
was also demonstrated by the PBMA panel in the mar-
ginal analysis task. The early years life course stage re-
ceived the highest number of first rankings. The early
years of the life course stages also received a higherTable 7 Results of the marginal analysis ranking exercise for
Life course stage Total number of times the stage
was assigned 1st ranking
Early years (including prenatal and
maternal health)
4
School aged children (3–11 years) 1
Children and young adults (12–17 years) 2
Working aged adults (18–65 years) 2
Older people (66–80 years) 1
(Frail) elderly (80 + years) 0proportion of the £5 million that later stages of life
with reasons highlighted that focusing on early inter-
vention could provide the greatest potential to gain in
the long-term. It is worth noting there is no similar
pressure for clinical services to be assessed in this way.
From an economic perspective clinical and public
health interventions can both be seen as having a com-
mon objective – to produce health benefits and the key
issue should therefore be to identify which types of
intervention produce the most health benefits and wider
social benefits per £ on the margin. It is thus arguably dis-
ingenuous to demand that public health interventions
demonstrate an “invest to save” benefit when we do not
expect this of new drugs and surgical interventions in the
NHS [23].
Limitations of the PBMA exercise
This exercise was the result of a direct request from the
Minister for Health and Social Care in Wales to review
the specific health improvement budget of £15.1 million.
This gave the exercise momentum; however, outside of
these contexts where there is not high level political sup-
port, the generalisability of this PBMA exercise may be
limited. It was recognised that across Welsh Government
there were other diverse budgets that could be linked withthe 6 life course stages from the 9 respondents
Total number of times the stage
was assigned 2nd ranking
Total number of times the stage
was assigned 3rd ranking
2 2
2 0
2 2
1 2
0 2
1 1
Figure 3 Results of the marginal analysis exercise - proportion
of the total allocation of the hypothetical £5 million for the 6
life course stages from the 9 respondents.
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ing with local government and the voluntary sector. This
meant that we were, at best, undertaking a “partial ana-
lysis”, and needed to keep in mind wider patterns of
spending, as far as these could be identified in the time
allowed. Common themes and concerns highlighted by
the authors that emerged from the three PBMA sessions
are summarised in Table 8.
Another limitation of the PBMA exercise was the mar-
ginal analysis task. Due to time constraints the panel were
unable to complete the task as part of the face to faceTable 8 Key themes and concerns emerging from the
PBMA process and sessions as noted by the authors
Number Key themes and concerns
1 There is no readily available source of information on wider
spending in Welsh Government and Public Health Wales on
health improvement to provide the big picture context to
the exercise.
2 It is very difficult to find evidence of effectiveness and
cost-effectiveness relating specifically to different time
horizons or national versus local provision.
3 The panel may need information about the proportion of
the population who may take up a service when thinking
about budget share i.e. population affected.
4 What is the (purpose/function) role of the “budget” i.e., the
pot of money under consideration? What makes it different
from other budgets /pots of money?
5 How we might best assess the effect of combined
interventions and integrated approaches?
6 How we might best assess the effect of combined
interventions and integrated approaches?
7 Government priorities can sometimes be based upon serial
decision making rather than parallel decision making.group discussion sessions. Rather than omit this step, a
pragmatic, high level e-mail based task was devised. This
task was used to indicate the direction of travel and pro-
vide further recommendations for next steps; it is also
worth noting a strength of this task was that it made the
panel consider opportunity cost. However, only 9 PBMA
panel members completed the marginal analysis task.
Though these members were representative of the wider
group with regards to role and expertise, the lack of
response limits the potential wider applications of the
recommendations given in this task. As the panel
included front line clinical staff, we had 3 sessions to
make participation in this PBMA exercise as manageable
as possible given the work commitments of the members.
As many PBMA exercises are shown to be unsuccessful
[10] it was important that the panel completed all stages
of the process, including a marginal analysis task though
the limitations of the pragmatic task chosen here are
noted above. The smaller response rate may be attributed
to the fact that this task was conducted via e-mail rather
than in person.
Strengths of the PBMA exercise
This Health Improvement Review and the PBMA exercise
offered the first transparent detailed breakdown of spending
on 25 health improvement initiatives, within a ministerial
budget. This provided a starting point for Welsh Govern-
ment and Public Health Wales to expand the scope, if
required, and gain a greater understanding of what is spent
on health improvement in Wales. The review of initiatives
allowed the panel to see what programmes are currently
operating in Wales and suggest further improvements for
initiatives (e.g., targeting), alternate delivery systems or new
initiatives based upon NICE guidance. The PBMA exercise
also generated a list of interventions recommended by
NICE that are not currently being delivered in Wales as
part of potential next steps and further research. A next
step would be to generate evidence booklets for these,
estimating what could be achieved with e.g., £1 million
invested in any one of these new interventions. There
would be a need to see how they would dove-tail with exist-
ing interventions and goals. Using the definitions of success
categorised by Tsouparas and Frew [10] in their review, we
argue our PBMA exercise would be considered successful
in terms of the participants gaining a better understanding
of the area under interest. It would also be considered
successful as the recommendations were taken further in a
report to the Minister, with changes to resource allocation
made and the promotion of an evidence based culture in
order to aid future resource allocation decisions.
Conclusions
The PBMA exercise provided a useful platform to discuss
and prioritise public health initiatives in Wales, taking
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clinical effectiveness, cost-effectiveness and equity consid-
erations), stakeholder views on and alternative options for
delivery. The electronic voting on candidates for invest-
ment and disinvestment showed a clear recommendation
for total disinvestment in 4 initiatives and a recom-
mendation for partial disinvestment in 6 further initia-
tives due to lack of evidence for their effectiveness and
cost-effectiveness at the time. The marginal analysis
exercise indicated the direction of travel, the PBMA
panel and HIAG group members advocated shifting
funding to prioritise areas associated with large adverse
health and social care costs. Priority was given to interven-
tions that impact on sections of the population with the
poorest health e.g., obesity and tobacco control. The panel
also advocated focusing on early intervention, as this has
the potential to result in large gain in the long-term. The
evidence sub-groups were able to suggest which interven-
tions Wales could be prioritising based upon NICE guid-
ance. Wales spends a very small proportion of its NHS
budget on health improvement. This exercise helped dem-
onstrate the activity currently undertaken in the budget
and its impact on the population, which was currently
unknown. This was a necessary process to promote an
evidence based culture to help resource allocation deci-
sions, which has been promoted further since the com-
pletion of the exercise. Within the current climate of
“prudent healthcare”, we have demonstrated that, at a
National level, the PBMA process can reach decisions
about potential candidates for disinvestment and potential
investment in priority areas and life course stages. The
next steps are to estimate the financial and health gain
returns from reallocating resources released in this
process.
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